140 related articles for article (PubMed ID: 28187036)
21. Expression of glypican-3 is highly associated with pediatric hepatoblastoma: a systemic analysis.
Xiong XL; Qin H; Yan SQ; Zhou LS; Chen P; Zhao D
Asian Pac J Cancer Prev; 2015; 16(3):1029-31. PubMed ID: 25735325
[TBL] [Abstract][Full Text] [Related]
22. Apoptotic protein expression, glycogen content, DNA ploidy and cell proliferation in hepatoblastoma subtyping and their role in prognostication.
Chopra A; Iyer VK; Agarwala S; Mathur SR; Aron M; Gupta SD; Verma K
Pediatr Surg Int; 2010 Dec; 26(12):1173-8. PubMed ID: 20803149
[TBL] [Abstract][Full Text] [Related]
23. Fetal and neonatal hepatic tumors.
Isaacs H
J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
[TBL] [Abstract][Full Text] [Related]
24. [Glypican 3 expression in hepatoblastoma and its diagnostic implication].
Wang FH; Wen JM; Vong HT; Yip YC
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):806-9. PubMed ID: 24507097
[TBL] [Abstract][Full Text] [Related]
25. Variable antigen expression in hepatoblastomas.
Ramsay AD; Bates AW; Williams S; Sebire NJ
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):140-7. PubMed ID: 18227729
[TBL] [Abstract][Full Text] [Related]
26. Small cell undifferentiated (SCUD) hepatoblastomas: All malignant rhabdoid tumors?
Vokuhl C; Oyen F; Häberle B; von Schweinitz D; Schneppenheim R; Leuschner I
Genes Chromosomes Cancer; 2016 Dec; 55(12):925-931. PubMed ID: 27356182
[TBL] [Abstract][Full Text] [Related]
27. Small cells in hepatoblastoma lack "oval" cell phenotype.
Badve S; Logdberg L; Lal A; de Davila MT; Greco MA; Mitsudo S; Saxena R
Mod Pathol; 2003 Sep; 16(9):930-6. PubMed ID: 13679457
[TBL] [Abstract][Full Text] [Related]
28. Impact of postoperative complications on overall survival of patients with hepatoblastoma.
Becker K; Furch C; Schmid I; von Schweinitz D; Häberle B
Pediatr Blood Cancer; 2015 Jan; 62(1):24-8. PubMed ID: 25251521
[TBL] [Abstract][Full Text] [Related]
29. Surgical treatment strategy for advanced hepatoblastoma: Resection versus transplantation.
Uchida H; Sakamoto S; Sasaki K; Takeda M; Hirata Y; Fukuda A; Hishiki T; Irie R; Nakazawa A; Miyazaki O; Nosaka S; Kasahara M
Pediatr Blood Cancer; 2018 Dec; 65(12):e27383. PubMed ID: 30084209
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathologic implication of hepatic progenitor cell marker expression in hepatoblastoma.
Yun WJ; Shin E; Lee K; Jung HY; Kim SH; Park YN; Yu E; Jang JJ
Pathol Res Pract; 2013 Sep; 209(9):568-73. PubMed ID: 23920322
[TBL] [Abstract][Full Text] [Related]
31. Multidisciplinary management of hepatoblastoma in children: Experience from a developing country.
Shanmugam N; Scott JX; Kumar V; Vij M; Ramachandran P; Narasimhan G; Reddy MS; Kota V; Munirathnam D; Kelgeri C; Sundaram K; Rela M
Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27781375
[TBL] [Abstract][Full Text] [Related]
32. Hepatoblastoma: the Indiana experience with preoperative chemotherapy for inoperable tumors; clinicopathological considerations.
Heifetz SA; French M; Correa M; Grosfeld JL
Pediatr Pathol Lab Med; 1997; 17(6):857-74. PubMed ID: 9353826
[TBL] [Abstract][Full Text] [Related]
33. Tissue microarray immunohistochemical profiles of p53 and pRB in hepatocellular carcinoma and hepatoblastoma.
Azlin AH; Looi LM; Cheah PL
Asian Pac J Cancer Prev; 2014; 15(9):3959-63. PubMed ID: 24935581
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial fragmentation is crucial for c-Myc-driven hepatoblastoma-like liver tumors.
Wang D; Tian J; Yan Z; Yuan Q; Wu D; Liu X; Yang S; Guo S; Wang J; Yang Y; Xing J; An J; Huang Q
Mol Ther; 2022 Apr; 30(4):1645-1660. PubMed ID: 35085814
[TBL] [Abstract][Full Text] [Related]
35. The influence of preoperative chemotherapy and surgical technique in the treatment of hepatoblastoma--a report from the German Cooperative Liver Tumour Studies HB 89 and HB 94.
Fuchs J; Rydzynski J; Hecker H; Mildenberger H; Bürger D; Harms D; V Schweinitz D;
Eur J Pediatr Surg; 2002 Aug; 12(4):255-61. PubMed ID: 12369004
[TBL] [Abstract][Full Text] [Related]
36. Hepatoblastoma in a 14 month-old female.
Boscarelli A; Levi Sandri GB; Calisti A; Briganti V; Grillo RL; Lepiane P; Caporilli D; Ettorre GM
Clin Ter; 2015; 166(2):59-61. PubMed ID: 25945430
[TBL] [Abstract][Full Text] [Related]
37. Clinical significance of CD44 expression in children with hepatoblastoma.
Cai HY; Yu B; Feng ZC; Qi X; Wei XJ
Genet Mol Res; 2015 Oct; 14(4):13203-7. PubMed ID: 26535633
[TBL] [Abstract][Full Text] [Related]
38. Transcription factor FOXA3 promotes the development of Hepatoblastoma via regulating HNF1A, AFP, and ZFHX3 expression.
Zhan X; Zhao A
J Clin Lab Anal; 2021 Mar; 35(3):e23686. PubMed ID: 33368532
[TBL] [Abstract][Full Text] [Related]
39. Timing and magnitude of decline in alpha-fetoprotein levels in treated children with unresectable or metastatic hepatoblastoma are predictors of outcome: a report from the Children's Cancer Group.
Van Tornout JM; Buckley JD; Quinn JJ; Feusner JH; Krailo MD; King DR; Hammond GD; Ortega JA
J Clin Oncol; 1997 Mar; 15(3):1190-7. PubMed ID: 9060563
[TBL] [Abstract][Full Text] [Related]
40. Survival after liver transplantation for hepatoblastoma: a 2-center experience.
Browne M; Sher D; Grant D; Deluca E; Alonso E; Whitington PF; Superina RA
J Pediatr Surg; 2008 Nov; 43(11):1973-81. PubMed ID: 18970927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]